NASDAQ:INSM

Insmed Stock Insider Trading

etoro logo Buy INSM
*Your capital is at risk
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026

Insmed Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -95.02. In total, the insiders bought 463.08K and sold 356.62K INSM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-95.02
Buy 463.08K shares
Sell 356.62K shares
50% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Jan 02, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -95.02.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Apr 01, 2026
Buy
Stock Option (right to buy)
M-Exempt
Adsett Roger
Chief Operating Officer
C-Suite Officer 88 060
Value: $1.28M
Apr 01, 2026
Sell
Common Stock
S-Sale
Adsett Roger
Chief Operating Officer
C-Suite Officer 62 344
Value: $10.3M
Apr 01, 2026
Sell
Common Stock
S-Sale
Adsett Roger
Chief Operating Officer
C-Suite Officer 19 001
Value: $3.12M
Apr 01, 2026
Sell
Common Stock
S-Sale
Adsett Roger
Chief Operating Officer
C-Suite Officer 6 715
Value: $1.10M
Apr 01, 2026
Buy
Common Stock
M-Exempt
Adsett Roger
Chief Operating Officer
C-Suite Officer 88 060
Value: $1.28M
Mar 30, 2026
Buy
Stock Option (right to buy)
M-Exempt
Smith Michael Alexander
Chief Legal Officer
Officer 5 649
Value: $96.4K
Mar 30, 2026
Sell
Common Stock
S-Sale
Smith Michael Alexander
Chief Legal Officer
Officer 19 638
Value: $2.96M
Mar 30, 2026
Buy
Stock Option (right to buy)
M-Exempt
Smith Michael Alexander
Chief Legal Officer
Officer 13 989
Value: $390.2K
Mar 30, 2026
Buy
Common Stock
M-Exempt
Smith Michael Alexander
Chief Legal Officer
Officer 5 649
Value: $96.4K
Mar 30, 2026
Buy
Common Stock
M-Exempt
Smith Michael Alexander
Chief Legal Officer
Officer 13 989
Value: $390.2K
Mar 19, 2026
Buy
Stock Option (right to buy)
M-Exempt
Lewis William
Chair And CEO
CEO / President 4 440
Value: $76.2K
Mar 19, 2026
Buy
Stock Option (right to buy)
M-Exempt
Lewis William
Chair And CEO
CEO / President 6 259
Value: $190.6K
Mar 19, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 4 533
Value: $653.3K
Mar 19, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 4 537
Value: $650.7K
Mar 19, 2026
Buy
Common Stock
M-Exempt
Lewis William
Chair And CEO
CEO / President 6 259
Value: $190.6K
Mar 19, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 1 629
Value: $231.6K
Mar 19, 2026
Buy
Common Stock
M-Exempt
Lewis William
Chair And CEO
CEO / President 4 440
Value: $76.2K
Mar 05, 2026
Buy
Stock Option (right to buy)
M-Exempt
Lewis William
Chair And CEO
CEO / President 6 259
Value: $190.6K
Mar 05, 2026
Buy
Stock Option (right to buy)
M-Exempt
Lewis William
Chair And CEO
CEO / President 4 440
Value: $76.2K
Mar 05, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 2 128
Value: $314.0K
Mar 05, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 3 899
Value: $571.8K
Mar 05, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 2 589
Value: $376.1K
Mar 05, 2026
Buy
Common Stock
M-Exempt
Lewis William
Chair And CEO
CEO / President 6 259
Value: $190.6K
Mar 05, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 2 083
Value: $300.4K
Mar 05, 2026
Buy
Common Stock
M-Exempt
Lewis William
Chair And CEO
CEO / President 4 440
Value: $76.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT INSMED
Insmed
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE